Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.

Both the ability of malignant cells to form multicellular aggregates via homotypic or heterotypic aggregation and their adhesion to the endothelium are important if not critical during early stages of cancer metastasis. The tumor-associated carbohydrate Thomsen-Friedenreich antigen (T antigen) and beta-galactoside binding lectins (galectins) have been implicated in tumor cell adhesion and tissue invasion. In this study, we demonstrate the involvement of T antigen in both homotypic aggregation of MDA-MB-435 human breast carcinoma cells and their adhesion to the endothelium. The T antigen-specific peptide P-30 (HGRFILPWWYAFSPS) selected from a bacteriophage display library was able to inhibit spontaneous homotypic aggregation of MDA-MB-435 cells up to 74% in a dose-dependent manner. Because T antigen has beta-galactose as a terminal sugar, the expression profile of beta-galactoside-binding lectins (galectins) in MDA-MB-435 cells was studied. Our data indicated the abundant expression of [35S]methionine/cysteine-labeled galectin-1 and galectin-3 in this cell line, which suggested possible interactions between galectins and T antigen. As revealed by laser confocal microscopy, both galectin-1 and galectin-3 also participate in the adhesion of the MDA-MB-435 cells to the endothelium. We observed the clustering of galectin-3 on endothelial cells at the sites of the contact with tumor cells, consistent with its possible interaction with T antigen on cancer cells The galectin-1 signal, however, strongly accumulated at the sites of cell-cell contacts predominantly on tumor cells. The T antigen-specific P-30 significantly (50%) inhibited this adhesion, which indicated that T antigen participates in the adhesion of MDA-MB-435 breast cancer cells to the endothelium. The ability of synthetic P-30 to inhibit both the spontaneous homotypic aggregation of MDA-MB-435 cells and their adhesion to the endothelium (>70 and 50%, respectively) suggests its potential functional significance for antiadhesive therapy of cancer metastasis.

[1]  M. Ghazizadeh,et al.  Specific Role of T and Tn Tumor‐associated Antigens in Adhesion between a Human Breast Carcinoma Cell Line and a Normal Human Breast Epithelial Cell Line , 1999, Japanese journal of cancer research : Gann.

[2]  K. Pienta,et al.  Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. , 1998, Journal of the National Cancer Institute.

[3]  S. Deutscher,et al.  Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries. , 1997, Journal of molecular biology.

[4]  S. Barondes,et al.  Strikingly Different Localization of Galectin-3 and Galectin-4 in Human Colon Adenocarcinoma T84 Cells , 1997, The Journal of Biological Chemistry.

[5]  G. Glinsky,et al.  Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. , 1997, Cancer letters.

[6]  R. Kerbel,et al.  Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors. , 1996, Human cell.

[7]  J. Price,et al.  Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. , 1996, Cancer research.

[8]  H. Inohara,et al.  Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. , 1996, Cancer research.

[9]  G. Glinsky,et al.  Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death , 1996 .

[10]  K. Pienta,et al.  Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. , 1995, Journal of the National Cancer Institute.

[11]  S. Barondes,et al.  L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. , 1993, The Journal of biological chemistry.

[12]  S. Barondes,et al.  Soluble lactose-binding lectin from rat intestine with two different carbohydrate-binding domains in the same peptide chain. , 1993, The Journal of biological chemistry.

[13]  S. Hakomori,et al.  Possible functions of tumor-associated carbohydrate antigens. , 1991, Current opinion in immunology.

[14]  J. Price,et al.  Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. , 1990, Cancer research.

[15]  S. Barondes,et al.  Multiple soluble beta-galactoside-binding lectins from human lung. , 1987, The Journal of biological chemistry.

[16]  R. Lotan,et al.  Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization. , 1986, Cancer research.

[17]  G. Springer.  T and Tn, general carcinoma autoantigens. , 1984, Science.

[18]  D. Glaves.  Correlation between circulating cancer cells and incidence of metastases. , 1983, British Journal of Cancer.

[19]  V. Schirrmacher,et al.  Proposed molecular basis of murine tumor cell-hepatocyte interaction. , 1983, The Journal of biological chemistry.

[20]  T. Springer,et al.  Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. , 1982, Journal of immunology.

[21]  G. Springer,et al.  Common precursors of human blood group MN specificities. , 1974, Biochemical and biophysical research communications.

[22]  I. Fidler.  The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. , 1973, European journal of cancer.

[23]  A. Al-Mehdi,et al.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.

[24]  M. Ghazizadeh,et al.  T/Tn pancarcinoma autoantigens: fundamental, diagnostic, and prognostic aspects. , 1995, Cancer detection and prevention.

[25]  R. Kerbel,et al.  Multicellular resistance: a new paradigm to explain aspects of acquired drug resistance of solid tumors. , 1994, Cold Spring Harbor symposia on quantitative biology.

[26]  I. Fidler,et al.  Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. , 1991, Invasion & metastasis.

[27]  G. Springer.  Tn epitope (N-acetyl-D-galactosamine alpha-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. , 1989, Molecular immunology.

[28]  S. Hakomori,et al.  Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. , 1989, Advances in cancer research.